Rowan Commits $50 Million To Cooper Medical School

Rowan University has committed $50 million over 10 years to significantly enhance medical and bioscience research at the Cooper Medical School of Rowan University in the City of Camden, the university announced on Wednesday.

The Board of Trustees at Rowan committed the money last week, and Cooper University’s Health Care Board voted on Wednesday to commit to helping build a medical research program focused on recruiting top research and clinical faculty to develop breakthrough medical cures and treatments.

“Medical research programs, as we envision at Cooper Medical School of Rowan University, have great potential to impact education, our health care system, and the economy,” Rowan University President Dr. Ali A. Houshmand said in a prepared statement. “We believe this investment and the collaboration with Cooper University Health Care physicians will build upon Cooper Medical School of Rowan University’s strong reputation and strengthen Camden’s ‘eds and meds’ corridor as an important destination for medical and bioscience research, and is in keeping with our recent designation as a Carnegie research institution.”

Houshmand said the university’s investment will boost the City of Camden’s revitalization efforts and create new economic opportunities in the “eds and meds” corridor.

“As the leading academic health system in South Jersey, Cooper knows how significant medical and bioscience research programs are to developing the next generation of breakthrough treatments and cures,” Cooper University Health Care Chairman George E. Norcross III said. “Cooper’s Board is in full support of Rowan’s investment and committed to creating a first-rate research program at Cooper Medical School of Rowan University. Attracting top students and health care professionals benefits patients, it benefits our health care system and it provides additional economic opportunities in Camden.”

The attached image was provided by Rowan University